TB PRACTECAL | A groundbreaking clinical trial to treat MDR-TB

STREAM multidrug resistant tuberculosis clinical trialПодробнее

TUBERCULOSIS: TB PRACTECAL - a cutting-edge clinical trialПодробнее

STREAM clinical trial for MDR-TBПодробнее

Second line medications for MDR-TB treatment; new drugs in the pipelineПодробнее

MDR-TB in 2015: Challenges and OpportunitiesПодробнее

How can we treat multi-drug resistant tuberculosis?Подробнее

WORLD TB DAY 2022 | Celebrating a new DR-TB treatment regimenПодробнее

TB PRACTECAL | Behind the groundbreaking work to beat an overlooked crisisПодробнее

TB 2022 International Conference New Treatment RegimenПодробнее

New TB Treatment RegimensПодробнее

Basics of transmission control in an era of MDR-TB treatmentПодробнее

MDR-TB: Speeding up research effortsПодробнее

Rapid Release of Safer Drugs for MDR TuberculosisПодробнее

WHO guideline on treatment of drug-resistant tuberculosis, 2022 updateПодробнее

MDR-TB, XDR-TB, and TDR-TB. Is This Progress?Подробнее

Treatment of MDR/XDR-TB: Patient selection and regimen designПодробнее

Researchers sharing with communities (part 2): Shorter regimens for drug resistant TBПодробнее

Landmark trial redefines MDRTB treatment: #endtb clinical trial results presentationПодробнее

MDR-TB Special Part 1 with Dr Paula FujiwaraПодробнее